12 Einträge gefunden

1. Immunohistochemically detected IDH1 mutation is rare and mostly heterogeneous in prostate cancer

   1. Hinsch, Andrea
   2. Brolund, Meta
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Möller-Koop, Christina
   7. Sauter, Guido

   2018 - Forschungsinformationssystem des UKE
2. High expression of class III β-tubulin in upper gastrointestinal cancer types

   1. Höflmayer, Doris
   2. Öztürk, Eray
   3. Schroeder, Cornelia
   4. Hube-Magg, Claudia
   5. Blessin, Niclas C
   6. Simon, Ronald
   7. Lang, Dagmar S

   2018 - Forschungsinformationssystem des UKE
3. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

   1. Gerhauser, Clarissa
   2. Favero, Francesco
   3. Risch, Thomas
   4. Simon, Ronald
   5. Feuerbach, Lars
   6. Assenov, Yassen
   7. Heckmann, Doreen

   2018 - Forschungsinformationssystem des UKE
4. EZH2 overexpression in head and neck cancer is related to lymph node metastasis

   1. Nienstedt, Julie C
   2. Schroeder, Cornelia
   3. Clauditz, Till
   4. Simon, Ronald
   5. Sauter, Guido
   6. Muenscher, Adrian
   7. Blessmann, Marco

   2018 - Forschungsinformationssystem des UKE
5. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

   1. Büscheck, Franziska
   2. Fraune, Christoph
   3. Simon, Ronald
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Möller-Koop, Christina
   7. Shadanpour, Navid

   2018 - Forschungsinformationssystem des UKE
6. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

   1. Li, Wenchao
   2. Blessin, Niclas C
   3. Simon, Ronald
   4. Kluth, Martina
   5. Fischer, Kristine
   6. Hube-Magg, Claudia
   7. Makrypidi-Fraune, Georgia

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
7. Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

   1. Berger, Lars-Arne
   2. Janning, Melanie
   3. Velthaus, Janna-Lisa
   4. Ben-Batalla, Isabel
   5. Schatz, Stefanie
   6. Falk, Markus
   7. Iglauer, Peter

   2018 - Forschungsinformationssystem des UKE
8. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

   1. Grupp, Katharina
   2. Hofmann, Bianca
   3. Kutup, Asad
   4. Bachmann, Kai
   5. Bogoevski, Dean
   6. Melling, Nathaniel
   7. Uzunoglu, Faik Guntac

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
9. BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy

   1. Oing, Christoph
   2. Tennstedt, Pierre
   3. Simon, Ronald
   4. Volquardsen, Jennifer
   5. Borgmann, Kerstin
   6. Bokemeyer, Carsten
   7. Petersen, Cordula

   2018 - Forschungsinformationssystem des UKE
10. Upregulation of centromere protein F is linked to aggressive prostate cancers

    1. Göbel, Cosima
    2. Özden, Cansu
    3. Schroeder, Cornelia
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Möller-Koop, Christina
    7. Neubauer, Emily

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
11. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor Features: A tissue microarray study on 8,877 human cancers and normal tissues

    1. Burdelski, Christoph
    2. Jakani-Karimi, Nilofar
    3. Jacobsen, Frank
    4. Möller-Koop, Christina
    5. Minner, Sarah
    6. Simon, Ronald
    7. Sauter, Guido

    2018 - Forschungsinformationssystem des UKE
12. Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    1. Heumann, Asmus
    2. Kaya, Özge
    3. Burdelski, Christoph
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Lang, Dagmar S
    7. Simon, Ronald

    2018 - Forschungsinformationssystem des UKE